Gallopamil Treatment: Latest Research Findings on Calcium Antagonism for Heart Health & Hypertension Management" （注：根据Google SEO优化规范，标题应简洁、包含关键词、并明确传达内容主题。此优化标题： 1. 突出核心关键词"Gallopamil Treatment"和"Calcium Antagonism" 2. 增加具体健康领域（Heart Health & Hypertension Management）以提升搜索相关性 3. 符合英文标题首字母大写的惯例 4. 未使用中文故无需翻译）

Calcium antagonists are currently the most extensively investigated drugs for the treatment of heart disease. They are used worldwide with great success and a comparatively low incidence of adverse reactions. The most prevalent and threatening diseases in modem industrialized societies - the various forms and complications of coronary arteriosclerosis and arterial hypertension - are amenable to treatment with calcium antagonists. The pharmacological spectrum of calcium antagonists is highly specific and was supplemen­ ted a few years ago by gallopamil, a verapamil analogue. The experimental work reported at this symposium was concerned with effects of gallopamil on the electrophysiology of the heart, particularly in acute myocardial ischemia. New therapeutic features of myocardial hypertrophy and hypertrophic cardiomyopathy are discussed. In medical practice, gallopa­ mil has proved particularly useful for the treatment of angina pectoris. Studies comparing gallopamil with other calcium antagonists are described to profile the properties of the drugs in terms of their specific therapeutic value. There is still a need for more differential therapeutic trials. This first international symposium on gallopamil was attended by experts from institutions devoted to theoretical and clinical research and general practice.